Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR: Individualized Antibiotic Duration for CAP
NCT04166110Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in community acquired pneumonia (CAP) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Cure rate at day 15. Planned start Sep 2023; status: not yet recruiting.
02
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT04166110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04166110.